MAZE THERAPEUTICS INC (MAZE:NASDAQ)
$24.06 -0.03 (-0.1245%)
Analysed MAZE THERAPEUTICS INC (MAZE:NASDAQ) News Sources
What Makes Maze Therapeutics (MAZE) One of the Best Oversold Small-Cap Stocks to Buy
26-04-2026
yahoo.com
Maze Therapeutics CSBO Sells 7,500 Shares for $190,000 After Strong Trial Results and Q4 Financials
07-05-2026
fool.com
A Look At Maze Therapeutics (MAZE) Valuation After Recent Share Price Weakness
12-05-2026
yahoo.com
Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
12-05-2026
yahoo.com
Maze Therapeutics, Inc. (MAZE) Reports Q1 Loss, Beats Revenue Estimates
12-05-2026
yahoo.com
Industry Analysts Just Made A Stunning Upgrade To Their Maze Therapeutics, Inc. (NASDAQ:MAZE) Revenue Forecasts
17-05-2026
yahoo.com
Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares
17-05-2026
fool.com
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
27-05-2026
yahoo.com
Maze Therapeutics' CEO Sold Over 30,000 Company Shares. What Does That Mean for Investors?
05-06-2026
fool.com
Maze Therapeutics (MAZE): 8 Oversold Stocks to Buy Right Now
08-06-2026
yahoo.com
What is the current price of MAZE THERAPEUTICS INC (MAZE:NASDAQ)?
The current price of MAZE THERAPEUTICS INC (MAZE:NASDAQ) is $24.06.
MAZE THERAPEUTICS INC (MAZE:NASDAQ) absolute price change since previous trading day?
The absolute price change of MAZE THERAPEUTICS INC (MAZE:NASDAQ) since the previous trading day is $-0.03.
MAZE THERAPEUTICS INC (MAZE:NASDAQ) percentage price change since previous trading day?
The percentage price change of MAZE THERAPEUTICS INC (MAZE:NASDAQ) since the previous trading day is -0.1245%.
What is the most recent average sentiment score for MAZE THERAPEUTICS INC (MAZE:NASDAQ)?
The most recent average sentiment score for MAZE THERAPEUTICS INC (MAZE:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for MAZE THERAPEUTICS INC (MAZE:NASDAQ)?
The most recent sentiment for MAZE THERAPEUTICS INC (MAZE:NASDAQ) is .
SEC-8K** Filing Available For MAZE THERAPEUTICS INC (MAZE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.